Skip to main content
Livermore
Livermore
ZHEN

Dodge & Cox

SEC CIK
0000200217
Latest filing
Aug 13, 2026

BMRN holding history

Biomarin Pharmaceutical Inc in every 13F filed by Dodge & Cox, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BMRN overviewAll 13F holders of BMRNFull Q2 2026 holdings

Shares (Q2 2026)
14,844,930
Value
$849.4M
% of portfolio
0.4%
Quarters held
22
Since Q1 2021
Holdings of BMRN by Dodge & Cox, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202614,844,930$849.4M0.4%+283,171+1.9%AddedHolders
Q1 202614,561,759$822.6M0.5%−10,625−0.1%ReducedHolders
Q4 202514,572,384$866.0M0.5%−114,417−0.8%ReducedHolders
Q3 202514,686,801$795.4M0.4%−421,509−2.8%ReducedHolders
Q2 202515,108,310$830.5M0.5%+153,070+1.0%AddedHolders
Q1 202514,955,240$1.06B0.6%+209,005+1.4%AddedHolders
Q4 202414,746,235$969.3M0.6%+847,917+6.1%AddedHolders
Q3 202413,898,318$976.9M0.6%−32,175−0.2%ReducedHolders
Q2 202413,930,493$1.15B0.7%−62,450−0.4%ReducedHolders
Q1 202413,992,943$1.22B0.7%−1,1200.0%ReducedHolders
Q4 202313,994,063$1.35B0.9%−159,440−1.1%ReducedHolders
Q3 202314,153,503$1.25B0.8%−136,800−1.0%ReducedHolders
Q2 202314,290,303$1.24B0.8%−39,010−0.3%ReducedHolders
Q1 202314,329,313$1.39B0.9%−54,350−0.4%ReducedHolders
Q4 202214,383,663$1.49B1.0%−390,300−2.6%ReducedHolders
Q3 202214,773,963$1.25B0.9%−233,100−1.6%ReducedHolders
Q2 202215,007,063$1.24B0.9%−27,936−0.2%ReducedHolders
Q1 202215,034,999$1.16B0.7%+209,950+1.4%AddedHolders
Q4 202114,825,049$1.31B0.8%+6,4670.0%AddedHolders
Q3 202114,818,582$1.15B0.7%+716,485+5.1%AddedHolders
Q2 202114,102,097$1.18B0.8%+2,247,789+19.0%AddedHolders
Q1 202111,854,308$895.1M0.6%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.